Texas Heart Institute and BiVACOR developed a metal-based Total Artificial Heart (TAH). Moreover, this new development will prolong the life of patients. Additionally, it will assist patients with biventricular, and univentricular, heart failure.
Furthermore, experts do not advise using left ventricular assist device support for Biventricular, and univentricular heart failures. So, termed as a ‘bridge-to-transplant solution’, TAH helps prolong life for heart patients waiting for donor’s hearts.
Baylor St. Luke Medical Center hosted the first-in-human transplant. Moreover, it is part of the FDA’s Early Feasibility Test (FES), dated July 9, 2024.
Also Read: Pakistani Teen’s Heart Transplant Journey In India: A Story Of Gratitude
The titanium-based heart uses a rotation pump to partially assist blood flow. However, it uses magnetically levitated rotors to pump blood, unlike previous devices.
The primary purpose of the device is not to replace the human heart entirely. However, it is to prolong the patient’s life until a donor is found.
